-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IVB-001 in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IVB-001 in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IVB-001 in Metabolic Dysfunction-Associated Steatotic Liver Disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Thyroid in Hypothyroidism
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Thyroid in Hypothyroidism report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thyroid in Hypothyroidism Drug Details: Armour thyroid is under development for the...
-
Product Insights
KRS Three (T3) Wind Farm
KRS Three (T3) Wind Farm is an onshore wind project located in Chaiyaphum, Thailand. The project is owned and developed by Wind Energy Holding Co Ltd. The project came online in 2018. Empower your strategies with our KRS Three (T3) Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IVB-003 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IVB-003 in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IVB-003 in Pancreatic Cancer Drug Details: IVB-003 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IVB-003 in Pancreatic Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.IVB-003 in Pancreatic CancerDrug Details:IVB-003 is under development for the treatment of pancreatic cancer. It is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Armour Thyroid in Hypothyroidism
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Armour Thyroid in Hypothyroidism report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Thyroid in Hypothyroidism
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Thyroid in Hypothyroidism report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Thyroid in HypothyroidismDrug Details:Armour thyroid is under development for the treatment of hypothyroidism. The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OV-329 in Tuberous Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OV-329 in Tuberous Sclerosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OV-329 in Tuberous Sclerosis Drug Details: Small molecule is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – T-3PY058739 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - T-3PY058739 in Solid Tumor report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MC-225 in Uremic (Renal) Pruritus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MC-225 in Uremic (Renal) Pruritus report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MC-225 in Uremic (Renal) Pruritus Drug Details: MC-225 is under...